Breakdown | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|
Income Statement | |||||
Total Revenue | 27.64B | 21.10B | 21.46B | 18.72B | 18.94B |
Gross Profit | 16.78B | 13.68B | 13.54B | 12.15B | 11.16B |
EBITDA | 4.42B | 3.07B | 3.37B | 2.62B | 2.55B |
Net Income | 1.98B | 1.09B | 1.73B | 1.48B | 1.13B |
Balance Sheet | |||||
Total Assets | 27.33B | 21.99B | 22.39B | 20.91B | 18.69B |
Cash, Cash Equivalents and Short-Term Investments | 1.35B | 1.71B | 2.66B | 3.32B | 3.13B |
Total Debt | 9.17B | 7.12B | 6.75B | 5.53B | 5.34B |
Total Liabilities | 16.66B | 13.12B | 13.00B | 11.26B | 9.90B |
Stockholders Equity | 9.94B | 8.66B | 9.23B | 9.50B | 8.79B |
Cash Flow | |||||
Free Cash Flow | 1.19B | 343.47M | 1.08B | 1.29B | 540.29M |
Operating Cash Flow | 1.76B | 1.91B | 1.97B | 1.90B | 3.12B |
Investing Cash Flow | -455.74M | -1.44B | -1.05B | -926.35M | -2.48B |
Financing Cash Flow | -1.58B | -1.48B | -1.70B | -843.95M | -455.07M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
73 Outperform | ¥9.71B | 20.11 | 5.50% | 3.88% | 0.84% | ||
71 Outperform | ¥26.38B | 12.69 | 0.60% | 31.02% | 76.65% | ||
67 Neutral | ¥277.48B | 14.89 | 6.81% | 2.50% | 5.07% | -22.68% | |
64 Neutral | $35.30B | 22.48 | 2.37% | 3.12% | 19.89% | -11.30% | |
59 Neutral | ¥25.30B | 77.89 | 0.61% | 2.98% | -42.40% | ||
56 Neutral | ¥6.21B | ― | 4.62% | -1.15% | 47.80% | ||
54 Neutral | ¥2.71B | 37.41 | 0.22% | 7.20% | 34.29% |